Northern Trust Corp Annexon, Inc. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Annexon, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,029,750 shares of ANNX stock, worth $2.61 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,029,750
Previous 790,065
30.34%
Holding current value
$2.61 Million
Previous $4.68 Million
12.94%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$18.7 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$17.7 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$16.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$15.9 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$14.2 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $120M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...